User Settings
Open AccessArticle10.4292/wjgpt.v3.i6.103

Is concomitant quadruple therapy for <i>Helicobacter pylori</i> eradication really needed for Japanese patients?

Vincenzo De Francesco,Angelo Zullo,Cesare Hassan-2012-01-01-World Journal of Gastrointestinal Pharmacology and Therapeutics

TL;DRAbstract

The study found that the 7 d of concomitant therapy (lansoprazole, amoxicillin, clarithromycin and metronidazole) achieved significantly higher eradication rates compared to 7 d of triple therapy (lansoprazole, amoxicillin, clarithromycin), the intention to treat (ITT) cure rates being 94.9% and 68.3%, respectively. According to our opinion, this study is clinically relevant for Japanese physicians for at least 2 reasons: (1) the standard triple therapy (clarithromycin plus amoxicillin) achieved disappointing cure rates in Japan - in agreement with what was observed in several countries; and (2) the concomitant quadruple therapy is an effective therapeutic alternative.

Chat with Paper

AI Agents for this Paper

The study found that the 7 d of concomitant therapy (lansoprazole, amoxicillin, clarithromycin and metronidazole) achieved significantly higher eradication rates compared to 7 d of triple therapy (lansoprazole, amoxicillin, clarithromycin), the intention to treat (ITT) cure rates being 94.9% and 68.3%, respectively. According to our opinion, this study is clinically relevant for Japanese physicians for at least 2 reasons: (1) the standard triple therapy (clarithromycin plus amoxicillin) achieved disappointing cure rates in Japan - in agreement with what was observed in several countries; and (2) the concomitant quadruple therapy is an effective therapeutic alternative.

Keywords

LansoprazoleClarithromycinConcomitantMetronidazoleAmoxicillinMedicineHelicobacter pyloriInternal medicine

Chat

Click to start Chat